endocardial fibroelastosis
MeSH: D004695ORPHA: 2022
Overview
endocardium disease that is characterized by endocardium becoming massively fibrosed and thickened wih elastic tissue resulting in a restrictive cardiomyopathy.
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with endocardial fibroelastosis, sourced from HPO and Orphanet clinical annotations.
Posteriorly rotated earsAbnormal palate morphologyMicrognathiaTelecanthusCongestive heart failureRestrictive cardiomyopathySandal gapHypoglycemiaAbnormal helix morphologyAbnormal cardiovascular system morphologyCognitive impairmentCryptorchidismAnterior hypopituitarismSeizureHypoplasia of penisEndocardial fibroelastosis
Classification & Codes
MeSH Code
D004695Orphanet Code
ORPHA:2022endocardial fibroelastosis
| MeSH | D004695 |
| Orphanet | ORPHA:2022 |
| Treatments | 0 drug(s) |
| Symptoms on record | 16 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO